Elevated PCSK9 occurs in a Brown Norway rat microbead model of glaucoma

被引:0
|
作者
Mysona, Barbara A. [1 ,2 ]
Zhao, Jing [1 ,2 ]
De Greef, Oceane [3 ]
Bollinger, Kathryn E. [2 ,4 ]
机构
[1] Augusta Univ, Cellular Biol & Anat, Augusta, GA USA
[2] James & Jean Culver Vis Discovery Inst, Augusta, GA USA
[3] Augusta Univ, STAR Program, Augusta, GA USA
[4] Augusta Univ Med Coll Georgia, Ophthalmol, Augusta, GA USA
关键词
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
1678
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome
    Olaniyi, Kehinde S.
    Areloegbe, Stephanie E.
    Areola, Emmanuel D.
    Sabinari, Isaiah W.
    Fafure, Adedamola A.
    Agbana, Richard D.
    Atuma, Chukwubueze L.
    ul haq Shah, Mohd Zahoor
    Ajadi, Isaac O.
    Olatunji, Lawrence A.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2023, 473
  • [42] Differential Expression of Renal and Hepatic PCSK9 during Development of Hypercholesterolemia in the Passive Heymann Nephritis Rat Model of Nephrotic Syndrome
    Molina-Jijon, Eduardo
    Mace, Camille E.
    Avila-Casado, Carmen
    Clement, Lionel C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [43] A safety and clinical efficacy analysis of PCSK9 monoclonal antibodies in patients with markedly elevated creatine phosphokinase levels
    Zafrir, B.
    Hislop, E.
    Volis, I.
    Saliba, W.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2938 - 2938
  • [44] PCSK9 Inhibition with alirocumab increases the catabolism of lipoprotein (a) particles in statin-treated patients with elevated lipoprotein(a)
    Watts, Gerald F.
    Chan, Dick C.
    Pang, Jing
    Ma, Louis
    Ying, Qidi
    Aggarwal, Shashi
    Marcovina, Santica M.
    Barrett, P. Hugh R.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 107
  • [45] ELEVATED SERUM PCSK9 IN NORMAL THIRD TRIMESTER PREGNANCY, PRE-ECLAMPSIA AND INTRAUTERINE GROWTH RESTRICTION
    Peticca, P.
    Gruslin, A.
    Cousins, M.
    Adetola, E.
    Mayne, J.
    Ooi, T.
    CANADIAN JOURNAL OF CARDIOLOGY, 2012, 28 (05) : S86 - S86
  • [46] SIRNA TO PCSK9 IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND ELEVATED LDL-C: THE ORION 1 TRIAL
    Ray, Kausik K.
    Landmesser, Ulf
    Leiter, Lawrence A.
    Kallend, David
    Wijngaard, Peter L. J.
    Wright, R. Scott
    Kastelein, John J. P.
    ATHEROSCLEROSIS, 2017, 263 : E9 - E10
  • [47] ACUTE PROGRESSION OF CORONARY DISEASE ON PCSK9 INHIBITION WITH ELEVATED LP(A) AND CORRECTED LDL-C OF ZERO
    Alam, Loba
    Fishberg, Robert
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 2778 - 2778
  • [48] Pregnancy in the brown Norway rat: A model for investigating the genetics of placentation
    Konno, Toshihiro
    Rempel, Lea A.
    Arroyo, Juan A.
    Soares, Michael J.
    BIOLOGY OF REPRODUCTION, 2007, 76 (04) : 709 - 718
  • [49] Oral sensitization to food proteins: a brown Norway rat model
    Knippels, LMJ
    Penninks, AH
    Spanhaak, S
    Houben, GF
    CLINICAL AND EXPERIMENTAL ALLERGY, 1998, 28 (03): : 368 - 375
  • [50] Suppression of PCSK9/NF-kB-dependent pathways by acetate ameliorates cardiac inflammation in a rat model of polycystic ovarian syndrome
    Olaniyi, Kehinde S.
    Areloegbe, Stephanie E.
    LIFE SCIENCES, 2022, 300